Wednesday, February 24, 2021
  • Login
  • Register
Southern News Network
Advertisement
  • Home
  • Kashmir
  • Jammu
  • National
  • Health
  • Business
  • Education
  • Ladakh
  • Sports
  • World
Southern News Network
  • Home
  • Kashmir
  • Jammu
  • National
  • Health
  • Business
  • Education
  • Ladakh
  • Sports
  • World
No Result
View All Result
Plugin Install : Cart Icon need WooCommerce plugin to be installed.
Southern News Network
No Result
View All Result

J&J pauses COVID-19 vaccine trials due to unexplained illness in participant

SNN DESK by SNN DESK
October 13, 2020
in Health
0 0
0
Home Health

(Reuters) – Johnson & Johnson JNJ.N said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest profile efforts to contain the global pandemic.

The participant’s illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company’s clinical and safety physicians, the company said here in a statement.

J&J, which reports quarterly financial results on Tuesday morning, said that such pauses are normal in big trials, which can include tens of thousands of people. It said the “study pause” in giving doses of the vaccine candidate was different from a “regulatory hold” required by health authorities. The current case is a pause.

However, J&J’s move follows a similar one by AstraZeneca Plc. In September, AstraZeneca AZN.L paused late-stage trials of its experimental coronavirus vaccine, developed with the University of Oxford, due to an unexplained illness in a UK study participant.

While trials in the UK, Brazil, South Africa and India have resumed, the U.S. trial is still on hold pending a regulatory review.

Dr. William Schaffner, a professor of infectious diseases at the Vanderbilt University School of Medicine, said by email that “Everybody is on the alert because of what happened with AstraZeneca,” adding that it could take a week to gather information.

“It would have to be a serious adverse event. If it was something like prostate cancer, uncontrolled diabetes or a heart attack – they wouldn’t stop it for any of those reasons. This is likely to be a neurological event,” he said.

Last month, J&J said its experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, following which the company kicked off a final 60,000-person trial, whose results had been expected by the end of this year or early 2021.

Johnson & Johnson declined to elaborate about the illness due to privacy concerns. It did say that some participants in studies get placebos, and it was not always clear whether a person suffering a serious adverse event in a clinical trial received a placebo or the treatment.

Stat News reported here the pause earlier in the day citing a document sent to outside researchers, which stated that a “pausing rule” had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened.

ShareTweetSendSharePinShareShare
SNN DESK

SNN DESK

Next Post
Sarpanch found hanging at his home in Bandipora village

Sarpanch found hanging at his home in Bandipora village

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Recent Posts

  • 2nd edition of ‘Khelo India Winter Games’ to begin at Gulmarg
  • Kashmir Wicker products now available online
  • Srinagar – Leh National Highway to be opened for regulated traffic from 28 Feb: Div Com Kashmir
  • South Kashmir: 02 Mlitants killed in Anantnag woods, operation on: IGP Kashmir
  • Transporters Call off Strike In J&K After ‘19% Fare Hike’

Recent Comments

    Southern News Network

    Powered By - Window Technologies

    Navigate Site

    • About Us
    • Contact Us
    • Home
    • Privacy Policy
    • Sample Page

    Follow Us

    No Result
    View All Result
    • Home
    • Kashmir
    • Jammu
    • National
    • Health
    • Business
    • Education
    • Ladakh
    • Sports
    • World

    Powered By - Window Technologies

    Welcome Back!

    Login to your account below

    Forgotten Password? Sign Up

    Create New Account!

    Fill the forms below to register

    All fields are required. Log In

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In

    Add New Playlist

    error: Content is protected !!